Evidence map›Paper›PMID 23847616›Full record

ArticleFrontiers in immunology2013

Therapeutic Potential of the Nitrite-Generated NO Pathway in Vascular Dysfunction.

Michael Madigan, Brian Zuckerbraun

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Effect of Alligator Weed (Animals : an open access journal from MDPI · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Antihistaminergic and Anticholinergic Properties of the Root Bark Aqueous Extract ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Arginase inhibition attenuates arteriogenesis and interferes with M2 macrophage accumulation.Laboratory investigation; a journal of technical methods and pathology · 2016
    Article
  11. Article
  12. Review
  13. Review
  14. Role of sGC-dependent NO signalling and myocardial infarction risk.Journal of molecular medicine (Berlin, Germany) · 2015
    Review
  15. Article
  16. The evolution of nitric oxide signalling in vertebrate blood vessels.Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2015
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael MadiganUniversity of Pittsburgh , Pittsburgh, PA , USA.
Brian Zuckerbraun
University of Pittsburgh · US

Funding

Heme Oxygenase Enzymes/Carbon Monoxide in Hepatic Dysfunction from hemorrhageR01GM082830 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZUCKERBRAUN, BRIAN SCOTT · 2010 to 2014
$1.5M
NIGMS NIH HHS R01 GM082830
6 · The paper itself

Abstract

Nitric oxide (NO) generated through L-arginine metabolism by endothelial nitric oxide synthase (eNOS) is an important regulator of the vessel wall. Dysregulation of this system has been implicated in various pathological vascular conditions, including atherosclerosis, angiogenesis, arteriogenesis, neointimal hyperplasia, and pulmonary hypertension. The pathophysiology involves a decreased bioavailability of NO within the vessel wall by competitive utilization of L-arginine by arginase and "eNOS uncoupling." Generation of NO through reduction of nitrate and nitrite represents an alternative pathway that may be utilized to increase the bioavailability of NO within the vessel wall. We review the therapeutic potential of the nitrate/nitrite/NO pathway in vascular dysfunction.

Indexed as

atherosclerosisneointimal hyperplasianitratenitric oxidenitriteperipheral vascular diseasepulmonary hypertensionreview

Identifiers

PMID23847616
PMCPMC3698458
OpenAlexW2022642257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.